|
LIXT Lixte Biotechnology Holdings Inc 1335105 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-6,078,593.00 |
| Balance Sheet |
|
Current Assets
|
$19,299,019.00 |
|
Assets
|
$26,648,865.00 |
|
Current Liabilities
|
$1,500,007.00 |
|
Liabilities
|
$1,661,026.00 |
|
Equity
|
$23,911,360.00 |
|
Shares Out
|
15417444.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,443,224.00 |
|
Investing Cash Flow
|
$-6,524,859.00 |
| Market Analysis |
Market Cap
|
$111,159,771.24 |
|
Price
|
$7.21 |
|
BVPS
|
1.55 |
|
PB
|
4.65 |
|
EPS
|
-0.16 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:50 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:40 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LIXT documents filed with the SEC.
LIXT Filings
Clear
